CARLING, WILLIAM R.,MARTOS, JOSE L.,KANGASMETSA, JUSSI J.,WANG, JENNY W.,WOODWARD, DAVID F.
申请号:
CA2860382
公开号:
CA2860382C
申请日:
2012.12.19
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
The present invention provides a compound, that is a 1-({halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compound may be represented by the following formula I, Wherein R1, R2, R3, R4 A, X, W, Z and Y are as defined in the specification. The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.